238 related articles for article (PubMed ID: 17681069)
1. Tissue levels of pyrimidine nucleoside phosphorylase activity in human and rodent bladder cancer and normal bladder tissue.
Fujimoto K; Matsumura Y; Tani Y; Ozono S; Hirao Y; Okajima E
Int J Urol; 2007 Aug; 14(8):754-9. PubMed ID: 17681069
[TBL] [Abstract][Full Text] [Related]
2. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase) and clinicopathological factors in patients with gastric cancer].
Onoyama H; Urakawa T; Azumi Y; Hashimoto Y; Sugihara S; Saitoh Y
Gan To Kagaku Ryoho; 2000 Jul; 27(7):1015-20. PubMed ID: 10925687
[TBL] [Abstract][Full Text] [Related]
3. [Histological study of urinary bladder tumor: DNA of rat urinary bladder tumor caused by N-butyl-N-(4-hydroxybutyl) nitrosamine and that of human bladder tumor].
Murase T; Kobayashi O; Aota Y; Mitsuta H; Koshikawa T
Hinyokika Kiyo; 1983 Mar; 29(3):303-10. PubMed ID: 6677123
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of pyrimidine nucleoside phosphorylase (PyNPase) in breast cancer].
Seo S; Miki A; Iwaisako K; Kamo N; Inomoto T; Kitai T; Ukikusa M
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1579-82. PubMed ID: 17108722
[TBL] [Abstract][Full Text] [Related]
5. [Effect of partial cystectomy on BBN-induced rat bladder cancer].
Aota Y
Hinyokika Kiyo; 1987 Feb; 33(2):204-9. PubMed ID: 3591583
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic effect of PyNPase (pyrimidine nucleoside phosphorylase) activity in breast cancer].
Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Matsuoka Y; Yamashita H; Fukuda M; Higuchi A; Masuyama S; Uchino S; Matsumoto H
Gan To Kagaku Ryoho; 1998 Jan; 25(1):59-66. PubMed ID: 9464330
[TBL] [Abstract][Full Text] [Related]
7. A study of antitumor effects of thymosin on rat and mouse urinary bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Wada S; Kinoshita Y; Kamizuru M; Asai Y; Iwata H; Ikemoto S; Hato F; Kishimoto T; Fukushima S
Oncol Res; 1996; 8(3):139-44. PubMed ID: 8823810
[TBL] [Abstract][Full Text] [Related]
8. Thymidine phosphorylase expression as a prognostic marker for predicting recurrence in primary superficial bladder cancer.
Aoki S; Yamada Y; Nakamura K; Taki T; Tobiume M; Honda N
Oncol Rep; 2006 Aug; 16(2):279-84. PubMed ID: 16820903
[TBL] [Abstract][Full Text] [Related]
9. [Significance of pyrimidine nucleoside phosphorylase and dihydropyrimidine dehydrogenase levels to predict postoperative recurrence in primary breast cancer].
Tamesa M; Yamamoto S; Maeda N; Nagashima Y; Oka M
Gan To Kagaku Ryoho; 2008 Mar; 35(3):431-6. PubMed ID: 18347391
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats.
Oliveira PA; Colaço A; De la Cruz LF; Lopes P; Lopes C
J Exp Clin Cancer Res; 2006 Sep; 25(3):425-32. PubMed ID: 17167984
[TBL] [Abstract][Full Text] [Related]
11. [Significance of pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in advanced gastric cancers].
Tsukayama S; Hirano M; Murakami N; Uno Y; Nozawa H; Yoshino H; Orta N; Kikkawa H; Masuda S
Gan To Kagaku Ryoho; 2001 May; 28(5):649-54. PubMed ID: 11383213
[TBL] [Abstract][Full Text] [Related]
12. Thymidine phosphorylase activity in human bladder cancer: difference between superficial and invasive cancer.
Kubota Y; Miura T; Moriyama M; Noguchi S; Matsuzaki J; Takebayashi S; Hosaka M
Clin Cancer Res; 1997 Jun; 3(6):973-6. PubMed ID: 9815773
[TBL] [Abstract][Full Text] [Related]
13. Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer.
Yamagata M; Mori M; Mimori K; Mafune KI; Tanaka Y; Ueo H; Akiyoshi T
Br J Cancer; 1999 Feb; 79(3-4):565-9. PubMed ID: 10027331
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/thymidine phosphorylase/platelet-derived endothelial cell growth factor and histological prognostic factor, and influence of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase activities and serum immunosuppressive acidic protein levels. A study group of oral anti-cancer drugs in Seiban/Tajima area].
Satoh B; Ohtoshi M; Ishida Y; Hen-mi K; Kaneko I; Soda M; Sugihara J; Shibagaki F; Iwai N; Nakamura T; Yamasaki T; Matsumoto S
Gan To Kagaku Ryoho; 1998 Feb; 25(3):359-64. PubMed ID: 9492829
[TBL] [Abstract][Full Text] [Related]
15. Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Ohtani M; Kakizoe T; Nishio Y; Sato S; Sugimura T; Fukushima S; Niijima T
Cancer Res; 1986 Apr; 46(4 Pt 2):2001-4. PubMed ID: 3948177
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathological significance of pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in advanced colorectal cancer].
Otsuka S; Tanabe S; Tsunemitsu Y; Ariki N; Miyoshi K; Inagaki M; Takahashi M; Oosaki T; Fuchimoto S; Yumura M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1679-81. PubMed ID: 16315907
[TBL] [Abstract][Full Text] [Related]
17. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Okajima E; Denda A; Ozono S; Takahama M; Akai H; Sasaki Y; Kitayama W; Wakabayashi K; Konishi Y
Cancer Res; 1998 Jul; 58(14):3028-31. PubMed ID: 9679967
[TBL] [Abstract][Full Text] [Related]
18. The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer.
Nonomura N; Nakai Y; Nakayama M; Inoue H; Nishimura K; Hatanaka E; Arima R; Kishimoto T; Miki T; Kuroda H; Okuyama A
Int J Clin Oncol; 2006 Aug; 11(4):297-302. PubMed ID: 16937303
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
Jancke G; Damm O; Rosell J; Jahnson S
Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
[TBL] [Abstract][Full Text] [Related]
20. DNA content analysis, expression of Ki-67 and p53 in rat urothelial lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and treated with mitomycin C and bacillus Calmette-Guérin.
Oliveira PA; Palmeira C; Colaço A; de la Cruz LF; Lopes C
Anticancer Res; 2006; 26(4B):2995-3004. PubMed ID: 16886626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
